The present Competitive Intelligence Report about Parathyroid Hormone (PTH) Receptor Agonists or PTH Analogs provides a competitor evaluation in the field of R&D projects with analogs of PTH used to stimulate the PTH receptor for the treatment of osteoporosis or other bone-related diseases as of January 2009. PTH analogs are recombinant and synthetic peptides delivered by injection, inhalation, nasal, oral and transdermal administration. The report includes a compilation of current active projects in research and development of PTH receptor agonists.
In addition, the report lists company-specific pipelines of PTH receptor agonists. Competitor projects are listed in a tabular format providing information on:
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Company
- Product Category
- Indication
- R&D Stage and additional comments with a hyperlink leading to the source of information.
